Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial

Autor:	Mazeraud, Aurélien *, Jamme, Matthieu *, Mancusi, Rossella Letizia *, Latroche, Claire *, Megarbane, Bruno, Siami, Shidasp, Zarka, Jonathan, Moneger, Guy, Santoli, Francesco, Argaud, Laurent, Chillet, Patrick, Muller, Gregoire, Bruel, Cedric, Asfar, Pierre, Beloncle, Francois, Reignier, Jean, Vinsonneau, Christophe, Schimpf, Caroline, Amour, Julien, Goulenok, Cyril, Lemaitre, Caroline, Rohaut, Benjamin, Mateu, Philippe, De Rudnicki, Stephane, Mourvillier, Bruno, Declercq, Pierre-Louis, Schwebel, Carole, Stoclin, Annabelle, Garnier, Marc, Madeux, Benjamin, Gaudry, Stéphane, Bailly, Karine, Lamer, Christian, Aegerter, Philippe, Rieu, Christine, Sylla, Khaoussou *, Lucas, Bruno *, Sharshar, Tarek
Zdroj:	In The Lancet Respiratory Medicine February 2022 10(2):158-166
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu